Lenacapavir

ATC J05AX31 · 9 markets · 21 records

Lenacapavir 9 markets · 21 records Forms

CA 4 records · 2 strengths

300 mgtabletSunlenca+1YEYTUO also in US·GB·ES
309 mgliquidSunlenca+1YEYTUO

US 3 records · 2 strengths

300 mgtabletSunlenca+1Yeztugo also in CA·GB·ES
50 mgtabletBIXLENVO

GB 2 records · 2 strengths

300 mgtabletSunlenca also in CA·US·ES
463.5 mg/1.5 mLinjectionSunlenca 464mg/1.5ml solution for injection vials

AU 2 records · 1 strengths

Records without a stated strength · 1 Sunlenca、YEYTUO

ES 2 records · 2 strengths

300 mgtabletSunlenca also in CA·US·GB
464 mginjectionSunlenca

MX 2 records · 2 strengths

Records without a stated strength · 2 Yeztugo Yeztugo

TW 2 records · 2 strengths

Records without a stated strength · 2 Sunlenca、尚能嘉膜衣錠 Sunlenca、尚能嘉注射劑

HK 2 records · 1 strengths

Records without a stated strength · 1 Sunlenca、Sunlenca solution for injection 463.5mg/1.5ml

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Sunlenca、YEYTUO

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.